Quantbot Technologies LP Ngm Biopharmaceuticals Inc Transaction History

Quantbot Technologies LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$1.05 - $3.37 $210 - $674	-200 Reduced 3.64%	5,300 $5,000
Q2 2023 Aug 08, 2023	BUY	$2.44 - $4.53 $3,718 - $6,903	1,524 Added 38.33%	5,500 $14,000
Q1 2023 May 12, 2023	SELL	$3.72 - $5.4 $19,872 - $28,846	-5,342 Reduced 57.33%	3,976 $16,000
Q4 2022 Feb 13, 2023	BUY	$3.41 - $12.93 $29,973 - $113,654	8,790 Added 1664.77%	9,318 $46,000
Q3 2022 Nov 07, 2022	SELL	$12.59 - $17.67 $68,036 - $95,488	-5,404 Reduced 91.1%	528 $6,000
Q2 2022 Aug 09, 2022	BUY	$10.58 - $17.5 $47,662 - $78,837	4,505 Added 315.7%	5,932 $76,000
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $52,105 - $70,177	-3,773 Reduced 72.56%	1,427 $21,000
Q4 2021 Feb 11, 2022	BUY	$17.26 - $22.02 $65,588 - $83,676	3,800 Added 271.43%	5,200 $92,000
Q3 2021 Nov 09, 2021	BUY	$20.15 - $26.19 $28,209 - $36,666	1,400 New	1,400 $29,000
Q1 2021 May 14, 2021	SELL	$24.99 - $31.93 $4,998 - $6,386	-200 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$16.21 - $31.44 $3,242 - $6,288	200 New	200 $6,000
Q3 2020 Nov 16, 2020	SELL	$15.59 - $19.97 $1,278 - $1,637	-82 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$11.97 - $23.47 $981 - $1,924	82 New	82 $1,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.